4
Oct
Rosacea is a common skin disorder primarily characterized by cutaneous hypersensitivity (1) and by the presence of chronic skin inflammation (2). It is a cutaneous problem generally affecting the central area of the face (cheeks, chin, nose, forehead), and the presence of the following visible signs in this region of the face is typically indicative of this disorder: flushing, erythema, telangiectasia, edema, papules, pustules, ocular lesions (3). Patients can be affected by one or a combination of these diagnostic signs that are commonly transient, can occur independently, and are often associated with collateral symptoms like burning and stining, plaques, skin dryness, ocular or peripheral manifestations (3). Affections to the eyes occur in about 50% of patients with rosacea, and even though the signs of rosacea predominantly appear on the face, the can also affect other areas of the body (4).
According to recent estimations (2011), rosacea affects about 14 million people in the United States (1), while an epidemiologic study in Sweden (2003) showed that its prevalence was 10% (5). It appears to be more frequently observed in fairskinned individuals of European and Celtic origin, although it has also been disagnosed in Asian and African American subjects (1). This chronic disorder affects both men and women, typically beginning after age 30 (6).
